Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07358858

A Food Effect Study of QLS1410 in Healthy Chinese Adults

A Randomized, Open-label, Two-period, Crossover Food Effect Study of QLS1410 in Healthy Chinese Adults

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
Qilu Pharmaceutical Co., Ltd. · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study is aimed to evaluate the effect of food on pharmacokinetics of QLS1410 in healthy Chinese adults.

Detailed description

All the qualified participants will be randomized (1:1) to two treatment sequences (fed/fasting and fasting/fed). In each period, participants will receive a single dosing of QLS1410 tablets either with or without a high-fat breakfast. There will be a one-week washout period in this study.

Conditions

Interventions

TypeNameDescription
DRUGQLS1410QLS1410 tablets

Timeline

Start date
2026-01-23
Primary completion
2026-02-07
Completion
2026-02-07
First posted
2026-01-22
Last updated
2026-01-22

Source: ClinicalTrials.gov record NCT07358858. Inclusion in this directory is not an endorsement.